1st Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Hepatology. 2017 Nov;66(5):1675-1688. doi: 10.1002/hep.29293. Epub 2017 Sep 29.
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by inflammation and fibrosis of the intra- and/or extrahepatic bile ducts. Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to diagnose PSC and detect disease related complications. Quantitative MRI technologies also have the potential to provide valuable prognostic information. Despite the potential of this imaging technology, the clinical application of MRI in the care of PSC patients and imaging standards vary across institutions. Moreover, a unified position statement about the role of MRI in the care of PSC patients, quality imaging standards, and its potential as a research tool is lacking.
Members of the International PSC Study Group and radiologists from North America and Europe have compiled the following position statement to provide guidance regarding the application of MRI in the care of PSC patients, minimum imaging standards, and future areas of research. (Hepatology 2017;66:1675-1688).
原发性硬化性胆管炎（PSC）是一种慢性胆汁淤积性肝病，其特征为肝内外胆管炎症和纤维化。磁共振成像（MRI）是一种非侵入性的成像方式，可用于诊断 PSC 并检测与疾病相关的并发症。定量 MRI 技术也有可能提供有价值的预后信息。尽管该影像学技术具有潜在价值，但 MRI 在 PSC 患者护理中的临床应用以及成像标准在各机构之间存在差异。此外，缺乏关于 MRI 在 PSC 患者护理中的作用、成像质量标准及其作为研究工具的潜在作用的统一立场声明。
国际 PSC 研究组的成员和来自北美和欧洲的放射科医生编写了以下立场声明，旨在为 MRI 在 PSC 患者护理中的应用、最低成像标准以及未来的研究领域提供指导。（Hepatology 2017；66:1675-1688）。
